Abstract:AIM:To find new antibacterial agents of quinolone with high activity and low toxicity.METHODS:To design and synthesize 7-(7-aminomethyl-5-azaspiro [2,4] hept-5-yl)-1-cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and its analogues, and to study their antibacterial activity in vitro and in vivo.RESULTS:Twenty new compounds (2 - 11, 17 - 26) were obtained including five targeted compounds (22 - 26). The structures of the compounds were confirmed by 1HNMR, MS and HRMS. Compounds 22 - 26 showed broad spectrum of antibacterial activity against Gram-positive and Gram-negative organisms. Especially for compound 24, the relevant MIC values for 13 strains of Gram-positive organisms were < 0.001 - 0.03 mg(-1), including 4 strains of S. pneumoniae, 2 strains of S. pyogenes, 3 strains of S. aureus and 2 strains of Enterococci which exhibited more potent activity than contrast agents (clinafloxacin and gatifloxacin). The MIC values of 24 for 6 strains Gram-positive organisms were 0.01 - 1 mg x L(-1), which exhibited equal or lower activity than contrast agents. They were more effective than ciprofloxacin and gatifloxacin against intraperitoneal infections caused by S. pneumoniae and S. aureus in mice.CONCLUSION:Compounds (23, 24 and 26) showed excellent antibacterial activity in vitro and in vivo and should be worth further investigation.

Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-methyl-4-methylaminopiperidin-1-yl)-fluoroquinolone derivatives.

Synthesis and in Vitro Antibacterial Activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone Derivatives.

Synthesis and in Vitro Antibacterial Activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone Derivatives

Design, Synthesis and in Vitro Antibacterial Activity of 7-(4-alkoxyimino-3-aminomethylpiperidin-1-yl)fluoroquinolone Derivatives.

Synthesis and in Vitro Antibacterial Activity of 7-(3-amino-6,7-dihydro-2-methyl-2h-pyrazolo[4,3-c] Pyridin-5(4h)-Yl)Fluoroquinolone Derivatives

Synthesis and in vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N'-alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines.

Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines.

Design, Synthesis, and in Vitro Antibacterial Activity of Fluoroquinolone Derivatives Containing a Chiral 3-(Alkoxyimino)-2-(aminomethyl)azetidine Moiety.

Synthesis and in Vitro Antibacterial Activity of 7-(4-Alkoxyimino-3-methyl-3-methylaminopiperidin-1-yl)quinolones.

Synthesis and in vitro antibacterial activity of 7-[3-(aminomethyl)- 4-(semicarbazono)pyrrolidin-1-yl]quinolone derivatives

Synthesis and in Vitro Antibacterial Activity of Quinolone/naphthyridone Derivatives Containing 3-Alkoxyimino-4-(methyl)aminopiperidine Scaffolds

[Synthesis and Antibacterial Activity of 7-(3-amino-4-alkoxyimino-1 -Piperidyl) -Quinolones].

Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo)methylpyrrolidine moiety

[Synthesis and Antibacterial Activity of 7-(7-aminomethyl-5-azaspiro [2,4] Hept-5-yl)-1-cyclopropyl-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid and Its Analogues].

Synthesis and antibacterial activity of 7-substited-5-azaspiro[2, 4] hept-5-yl quinolone-3-carboxylic acids

Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety.

Synthesis and Antibacterial Activity of Dl-7-( 4,4-Dimethyl-3-aminomethylpyrrolidinyl) -Quinolones

Synthesis and in Vitro Antibacterial Activities of 7-(4-alkoxyimino-3-hydroxypiperidin-1-yl)quinolone Derivatives

Synthesis and In‐Vitro Antimycobacterial Activity of Fluoroquinolone Derivatives Containing a Coumarin Moiety

Design, Synthesis and Antibacterial Evaluation of Novel Fluoroquinolone and its Derivatives

Design, Synthesis, Antibacterial Evaluation and Docking Study of Novel 2‐hydroxy‐3‐(nitroimidazolyl)‐propyl‐derived Quinolone